The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bryson Vaughn D since year 2005.
The trader's CIK number is 1189539.
At the time of this reporting, Bryson Vaughn D is the Director of Atherogenics Inc .
(stock ticker symbol AGIX).
See this page for all insider trading activities at Atherogenics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2005-05-06||AMLN||Amylin Pharmaceuticals Inc||Buy||20,000||16.72||334,300|
|2005-03-31||ICOS||Icos Corp / De||Buy||5,000||22.54||112,705|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bryson Vaughn D (Director of Atherogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.